Introduction: Numerous models have been described to study the pathogenesis of rheumatoid arthritis, and to develop new therapies; but each of these models has their own limitations. Nowadays, the collagen-induced arthritis (CIA) mouse model is the most commonly used model for rheumatoid arthritis studies in certain mouse strain like DBA/1 mouse. This study aimed to describe a new protocol for local induction of arthritis in Balb/c mice, including the monitoring of clinical arthritis and the protocols for histological examination of paws of mice.
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that affects primarily the joints and is manifested as pain, stiffness, and synovitis (inflammation of the synovial membrane) leading in turn to articular destruction. Animal models of autoimmune arthritis have been considered valuable research tools for studying pathogenic mechanisms of this disease as well as testing new treatments. Several mouse models of arthritis have been developed to facilitate understanding of the pathogenesis of RA and development of new therapies. However, the collagen-induced arthritis model (CIA) has been the most widely studied model of RA. CIA was first described in rats [1] and subsequently shown to be inducible in susceptible strains of mice [2] , following inoculation with type II heterologous collagen in complete Freund's adjuvant. Susceptibility to both RA and CIA is associated with the expression of specific class II major histocompatibility complex (MHC) molecules. [3, 4] Earlier studies have shown that DBA/1 mice with the H-2q haplotype had the highest susceptibility, whereas the H-2b and H-2 d haplotypes like C57BL/6 and Balb/c mice, respectively, showed the lowest responsiveness to immunization with collagen and adjuvant. Class II MHC haplotypes and antigen presentation of specific collagen peptides to T cells also modulate the responsiveness of mice, but the adapted induction schedule and the use of a higher concentration of Mycobacterium tuberculosis have indicated that CIA can be induced in mice strains that were previously considered to be unresponsive. [5, 6] The establishment of a CIA model in Balb/c mice enables researchers to investigate the role of specific genes, receptors, or immune mediators such as cytokines in knockout or transgenic mice, which are often on a Balb/c background. In this way, avenues arise to study new targets for drug development. Therefore, the primary aim of the current study was to introduce new local CIA model in non-susceptible Balb/c mice for understanding pathophysiology of RA, and developing new therapies on the disease.
Material and Methods

Animals
Forty male Balb/c mice (H-2 d ) (Experimental Animals Breeding and Research Center, Uludağ University, Bursa, Turkey), 6-8 weeks old were used. Before the experiments, they were housed five per cage at temperatures of (20-22°C) and humidity of (60-70%) in a controlled room set to a 12-h light: 12-h dark cycle and had access to standard mice chow and water ad libitum. The Animal Care and Usage Committee of Uludağ University, in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals, approved all experimental procedures. [7] 
Preparation of Collagen Type II Emulsion
Collagen is a fibrous protein that, at normal physiological conditions, is insoluble. Consequently, collagen type II from the bovine nasal septum (Sigma-Aldrich Co. LLC., cat. No. C7806-10 MG) was solubilized in a dilute solution of 0.1 M acetic acid (Sigma-Aldrich Co. LLC., cat. No. 38051-1EA) at the final concentration of 2 mg/ ml collagen.
Induction Local CIA in Balb/c Mice
Arthritis was induced right paw of the mice. Left paw of the mice was used as a control. The mice were anesthetized with sevoflurane (2-4%/O 2 100%). The 10 µl Hamilton syringe was filled with the final concentration of 2 mg/ ml collagen from the bovine nasal septum. Under the anesthesia, the injection area at the right knee joint and back of mice were cleaned with a wipe soaked in ethanol. A total of 10 µl collagen from bovine nasal septum emulsion (2 mg/ml) was injected carefully into the right knee joint with glass Hamilton syringe and 25G needles for intraarticular (i.a.) injection. Just after this, a total of 100 µl Complete Freund's adjuvant (CFA, Mycobacterium tuberculosis, heat killed and dried; Sigma-Aldrich Co. LLC., cat. No. F5881-6X10ML) emulsion is injected at the back of mice using the syringe with 25G needles subcutaneously (s.c.). When injected properly, a white lobule should be visible at the site of injection. The mice put back in their cages and expected to recover from anesthesia after the injections were completed. At day 14 after the first injection, the mice were injected i. a. with 10 µl of collagen from the bovine nasal septum (2 mg/kg) and s.c. with 100 µl CFA emulsion for boost injection.
Monitoring of Local Arthritis
Local arthritis was monitored using a clinical arthritis scoring system and paw swelling was measured with help of a caliper. Measurements were taken on day 0, 14, 21 and 30 days of induction as arthritis induced paws (right paw) and non-arthritis induced paws (left paw). Scoring was initiated on 0 day after administration of primary dose of collagen from the bovine nasal septum and CFA Table 1 shows how scores are assigned. To measure paw thickness of collagen treated hind ankle joint, mice were restrained by holding by the scruff of the neck and tail and then paw thickness were measured by using caliper. Always hold the caliper in the same way during each measurement.
Decalcification and Histological Examination of Mice Paws
At the end of the study, the mice were anesthetized with sevoflurane (2-4%/O 2 100%). They were sacrificed by cervical dislocation under the anesthesia. The hind paws of the mice were cut of the level of hips to keep the knee joint intact for histopathological examination. The skin of the hind paws was removed. After that, the tissue samples were fixed in 10% formalin solution for 48 hours at 37°C in an incubator.
The samples were put in decalcifying solution (10%, Ethylenediaminetetraacetic acid) for two weeks following the fixation process was completed. The decalcifying solution was changed every other day. Decalcified tissue samples were then processed routinely for histological examination. Briefly, 5 µm tissue sections were cut and mounted glass slides. All tissue sections were stained with Haematoxylin-Eosin (H&E) and evaluated light microscopically.
Results
Ten animals were used for day 0 observation. Those animals had first immunization but they did not show any clinical or histopathological sign on day 0 (Fig. 1, A , B, C). Second ten mice were sacrificed just after boost immunization (day 14). Those paws of mice showed clinically mild erythema around joint and histopathologically mild inflammatory cell infiltration (Fig. 1, D , E, F).
One week after the boost immunization (day 21), the paw clinically started to show severe erythema and swelling all around the right hindquarter of Balb/c mice on both days 21 (Fig. 1G, n=10 ) and these signs continued through day 30 (Fig. 1J, n=10 ) when they were compared the control paws. The local CIA arthritis induced paws (right) reached 4 times thicker than the non-arthritis induced paws (left) at the first week of the boost immunization (Fig. 2) . According to table 1 scoring the local CIA arthritis induced paw (right) and the control paw (left) of the mice were scored as "4" and "0", respectively, on both days 21 ( Fig.  1 , G, H) and 30 ( Fig. 1 , J, K). Fig. 1, I ) and 30 (Fig. 1, L) . Neovascularization, existence of synovial granulation tissue (pannus) extended into the cartilage surface, chondrocytes necrosis in cartilage, bone lysis and fibrinous material within joint space were also noticed on both days 21 ( Fig. 1, I ) and 30 (Fig. 1, L) . 
Discussion
In this study, we showed that Balb ⁄c mice were immunized with i.a. collagen from the bovine nasal septum and with s.c. CFA containing the amount of Mycobacterium tuberculosis. For boost immunization, the same mice had the same dose and route injections at day 14 after the first injection. After the boost immunization, the paw showed clinically and histologically long-lasting severe arthritis signs.
Collagen Type II-dependent both a T-cell and B-cellspecific response involves to the immunopathogenesis of CIA. there is some evidence that antibodies from RA patients target the same areas of the Collagen Type II molecule as those from CIA. [17] Identification of pathogenic B-cell determinants has proven to be more difficult owing to the requirement that the pathogenic antibodies must be able to bind to the triple helical native Collagen Type II. The pathogenesis of CIA is mediated, in a large part, by CII-specific antibody that binds to the cartilage, and is capable of fixing complement. In the present study Balb/c mice also required immunization with CFA for elicitation of a high incidence of arthritis. This is likely due to the stimulatory capacity of heat-killed Mycobacterium in the adjuvant, and its promotion of the inflammatory response that initiates an immune response to Collagen Type II. This concept is supported by the fact that a higher than usual concentration of the heat-killed Mycobacterium tuberculosis is required to elicit a high incidence of disease in the CIA model.
Animal models of autoimmune arthritis have proven to be valuable research tools for the study of pathogenic mechanisms of RA as well as for testing new therapies. Several mouse models of arthritis have been established.
[18] While each of these described models has advantages and disadvantages, CIA has been the most widely studied model of RA. It shares several pathological features with RA, and Collagen Type II is a major protein in cartilage, the target tissue of RA. Additionally, of the antigendefined models that are based on cartilage proteins, it has the shortest duration between immunization and disease manifestation. The CIA model has been used extensively to identify potential pathogenic mechanisms of autoimmunity, including the role of individual cell types in disease onset and progression, as well as to design and test new therapeutics. In recent years, the CIA model has been instrumental in the testing and development of the new biologically based therapeutics, such as those that target tumor necrosis factor-α, a cytokine produced by macrophages and T cells that is a dominant inflammatory mediator in the pathogenesis of RA. The development of these biologically based therapies has revolutionized the treatment of RA.
Susceptibility to CIA is linked to major histocompatibility complex-class II molecules which respond to individual species of type II collagen used for immunization. [19] It is known that the major histocompatibility complex and non-major histocompatibility complex genetic backgrounds make the mice strain highly susceptible to collagen antibody induced arthritis. Due to the specific genetic background, the Balb/c strain shows a strong predisposition toward collagen antibody induced arthritis or proteoglycan-induced arthritis but not CIA. [20] On the other hand, Balb/c mice are capable of producing arthritogenic antibodies, suggesting that CIA is not only restricted by MHC types. [21] In addition, despite the efforts of companies to maintain genetically homogenous inbred mouse colonies, there are differences among BALB/c colonies or substrains (for example, in body weight, size of littermates, and the composition of microbiota) maintained at different locations by the same vendor. According to the online public database of The Jackson Laboratory (Bar Harbor, ME, USA) [22] , there is at least 492 single nucleotide polymorphism (SNP) differences between their two inbred BALB/cJ and BALB/ cByJ colonies. Some of these polymorphisms or mutations may influence the predisposition of the mice to CIA. [20] Strain-specific differences in cytokine production provide us opportunities to understand the mechanisms responsible for cytokine control of susceptibility and resistance to autoimmune disease. It was reported that the bias toward a Th2 response in BALB/c mice might be regulated at two stages of the immune response. [23] [24] [25] Initially, there is an increase in the frequency of Th2 cells producing IL-4, which is conducted by a locus on chromosome 16. Then, loss of IL-12 responsiveness occurs due to the decrease in IL-12R expression, which is influenced by a locus on chromosome 11. Resistance to autoimmune disease in this model found to be correlated with differentiation of naive T cells into Th2-type cells. [25] Despite the predisposition of BALB/c mice to a Th2-type response, Finnegon et al. [26] demonstrated that induction of arthritis in Balb/c mice by proteoglycan is a Th1-type disease. The effectiveness of IL-4 treatment was particularly striking in their study since in other models of arthritis, treatment in a similar manner with IL-4 was not able to ameliorate arthritis. That study suggested that levels of endogenous IL-4 in BALB/c mice might increase their responsiveness to Th2 cytokine therapy. Similar studies should be employed in distinct BALB/c colonies or substrains to find out colonyor substrain-specific responses in autoimmune disease models.
Although it is accepted that Balb/c mice belong to strains of mice regarded to have low susceptibility to CIA, our results demonstrated that if mice are immunized with i.a. collagen from bovine nasal septum and with s.c. CFA at day 0, and are boosted with same regime on day 14, Balb/c mice developed arthritis with high incidence in a week.
Conclusion
Collectively, these data have enabled researchers to study a wide range of pathogenic mechanisms in this described local CIA model, as well as to design and test novel therapeutics.
